ADMA Biologics, Inc.
ADMA
$17.10
-$0.20-1.16%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 26.05% | -30.56% | 18.96% | -1.74% | 94.69% |
Total Receivables | 10.38% | 98.83% | -0.28% | 66.51% | -39.31% |
Inventory | 11.19% | 1.15% | -0.91% | -4.45% | 1.17% |
Prepaid Expenses | -5.83% | 6.97% | -15.88% | 72.79% | 47.66% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 13.57% | 6.16% | 4.15% | 4.78% | 9.87% |
|
|||||
Total Current Assets | 13.57% | 6.16% | 4.15% | 4.78% | 9.87% |
Net Property, Plant & Equipment | 1.11% | 3.77% | 1.20% | -1.40% | -1.91% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | 16.59% | -1.74% | -5.15% | 1.25% | 49.22% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -0.84% | -0.99% | 1,445.57% | 11.45% | -11.37% |
Total Assets | 9.36% | 4.48% | 25.10% | 3.78% | 7.27% |
|
|||||
Total Accounts Payable | 44.46% | 1.92% | 26.21% | 12.98% | -17.50% |
Total Accrued Expenses | 3.48% | -19.96% | 18.20% | 7.17% | -27.82% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -5.13% | -2.46% | 2.10% | 4.47% | 4.48% |
Total Finance Division Other Current Liabilities | 131.33% | 60.49% | 58.39% | -44.73% | 78.79% |
Total Other Current Liabilities | 131.33% | 60.49% | 58.39% | -44.73% | 78.79% |
Total Current Liabilities | 40.08% | -3.68% | 23.73% | 1.62% | -16.79% |
|
|||||
Total Current Liabilities | 40.08% | -3.68% | 23.73% | 1.62% | -16.79% |
Long-Term Debt | 1.20% | 0.26% | -28.61% | -22.70% | 0.17% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 12.09% | -3.07% | -3.43% | -3.45% | -3.21% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -14.54% | -12.20% | -11.68% | -1.38% | -1.33% |
Total Liabilities | 16.70% | -1.80% | -12.01% | -15.63% | -4.58% |
|
|||||
Common Stock & APIC | 0.89% | -0.38% | 0.80% | 1.20% | 0.39% |
Retained Earnings | 12.15% | 8.72% | 26.61% | 7.87% | 6.56% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 6.67% | 6.99% | 50.51% | 23.17% | 22.49% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.67% | 6.99% | 50.51% | 23.17% | 22.49% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.67% | 6.99% | 50.51% | 23.17% | 22.49% |
|